Cyclotides' exceptional stability (resistant to heat, enzymes, and chemicals) combined with their amenability to sequence grafting makes them ideal scaffolds for creating a new class of stable peptide drugs.
Nature's scaffoldCyclotides resist heat, enzymes, and chemicals while allowing drug sequences to be grafted in — nature solved the peptide stability problem
What the researchers found
Cyclotides combine exceptional structural stability (thermal, enzymatic, chemical resistance) with sequence-tolerant scaffolding capability, enabling design of stable peptide drugs through grafting bioactive sequences into the cyclotide framework.
Why it matters
Most peptide drugs fail because they're unstable in the body. Cyclotides solve this stability problem while maintaining the ability to present drug-like sequences, potentially enabling oral peptide drugs.
How the study worked
Review of cyclotide discovery, structural biology, stability properties, known bioactivities, and drug design applications including grafting strategies.
What this study cannot tell us
Drug design with cyclotides was still in early stages. Not all bioactive sequences can be successfully grafted. Manufacturing at pharmaceutical scale is challenging.
How to read the evidence
Moderate evidence from a review synthesizing structural, stability, and early drug design data for cyclotide scaffolds.
When this study was published
Published in 2002. Cyclotide drug design has advanced enormously, with grafted cyclotides now in preclinical development for cancer, pain, and cardiovascular diseases.
The bigger picture
Cyclotides represent a paradigm shift in peptide drug development. Instead of fighting peptide instability with chemical modifications, nature has provided a ready-made stable scaffold that drugs can be built upon.
Questions still open
- Can cyclotide-grafted drugs achieve oral bioavailability?
- Which therapeutic areas benefit most from cyclotide scaffolding?
- Can cyclotides be produced cost-effectively for pharmaceutical use?
Common questions
What makes cyclotides special for drug design?
What diseases could cyclotide drugs treat?
Read the original research
The cyclotides: novel macrocyclic peptides as scaffolds in drug design.
Current opinion in drug discovery & development, 5(2), 251-60
Citation
Craik, David J; Simonsen, Shane; Daly, Norelle L. (2002). The cyclotides: novel macrocyclic peptides as scaffolds in drug design.. Current opinion in drug discovery & development, 5(2), 251-60.